Analysis and consideration of pharmaceutical care on the patient with pulmonary heart disease by clinical pharmacist
WANG Yan-li
JIAO Ping
ZHU Man
Abstract：One 55-year-old female patient with chronic obstructive pulmonary disease for 30 years was hospitalized and diagnosed as pulmonary heart disease, right heart failure, NYHA class Ⅲ, type Ⅱ respiratory failure, acute exacerbation of chronic obstructive pulmonary disease, arrhythmia, atrial fibrillation with Ⅱ degree atrioventricular block. After admission, combined treatment including cefuroxime for anti-infection, salbutamol sulfate solution for expansion of the trachea, budesonide suspension for reducing inflammatory reactions, spironolactone tablets and furosemide injection for reducing cardiac preload, nitroglycerin injection for reducing cardiac afterload, dopamine hydrochloride injection for improving heart failure, warfarin sodium tablets for anticoagulation were given to the patient. The patient was improved and discharged with stable condition. Clinical pharmacist performed pharmaceutical care during the course of therapy through paying close attention on the potential drug interaction, the rational use of traditional Chinese medicine injections, the incompatibility of liquids, adverse drug reaction, communication with doctors, medication education, etc.
Keywords：Clinical pharmacistPulmonary heart diseasePharmaceutical care
Publication Date：2017-01-01
Pages：4( 281-284 )